EUVIMED · CrossrefJournal
Global Advances in Oncology and Hematology
ISSN 3118-250X · Ovid Technologies (Wolters Kluwer Health)
Latest articles
Gastric Cancer and Immunity: Reassessing the Immunoscore beyond Colorectal Cancer
A New Global Voice for Oncology and Hematology: Advancing Science without Borders
Synthetic Data and Generative AI in Oncology: A Global Bibliometric and Science-Mapping Analysis of 5,687 Publications
Cancer Incidence and Mortality Trends in the United Arab Emirates, 2011–2024: A National Epidemiological Analysis
GAOH Editorial Members
Public Awareness and Understanding of Palliative Care in the United Arab Emirates: Insights from a Population-Based Survey
The OPTIMA Phase III Trial: Methodological Considerations, Comparison with RxPONDER, and Balanced Interpretation of Test-Directed Chemotherapy De-escalation
Exceptional Pathological Complete Response Following Concurrent Neoadjuvant Pembrolizumab and Radiotherapy for Locally Advanced Cutaneous Angiosarcoma: A Multidisciplinary Case Report and Literature Review
Navigating an Uncertain Future: A Qualitative Study Exploring Thoughts on Fertility and Oncofertility Counseling Among Young Cancer Patients
Obesity and Cancer in the UAE: A Systematic Review of Lifestyle Factors and Cancer Risk
Can Axillary Surgery be Safely De-escalated in cN2/N3 Breast Cancer After Neoadjuvant Systemic Therapy?
When Is Dual Immunotherapy Most Appropriate in the Management of Metastatic Non-small Cell Lung Cancer?
Intensify Chemotherapy or Activate Immunity? Balancing INTERLACE and KEYNOTE-A18 in Locally Advanced Cervical Cancer
Durvalumab after Chemoradiotherapy for the Treatment of Patients with Stage III Non-Small Cell Lung Cancer: A Lebanese Real-World Study
EUVIMED